In this technical guide you will learn about: The fully automated method for the high-throughput transformation and growth of bacteria cells How to improve robustness and reproducibility of your experiments How the transformation of DNA into bacteria cells, such as Escherichia coli (E. coli), is an essential molecular biology technique used for both the study […]

This whitepaper includes an introduction to antibodies and the process of antibody engineering based on Absolute Antibody’s years of experience developing recombinant versions of antibodies for a wide range of clients. This whitepaper will be valuable to: Therapeutic antibody developers Researchers designing antibodies for diagnostics Researchers looking to refine assays, antibody half-life or alter function […]

Advancements in antibody engineering technologies have greatly enhanced the generation of recombinant antibodies in various formats as therapeutic agents. There are already more than 100 antibody-based drugs approved by the FDA, and numerous antibodies are currently in their late-stage clinical studies. Compared to monoclonal antibodies produced using traditional hybridoma techniques, recombinant antibodies offer advantages, such […]

Advancements in antibody engineering technologies have greatly enhanced the generation of recombinant antibodies in various formats as therapeutic agents. There are already more than 100 antibody-based drugs approved by the FDA, and numerous antibodies are currently in their late-stage clinical studies. Compared to monoclonal antibodies produced using traditional hybridoma techniques, recombinant antibodies offer advantages, such […]

This 28-page DDW eBook, sponsored by Bio IVT, contains exclusive insight from industry experts on: Cell & gene therapies: the challenges and trends Battling the bottleneck: leveraging education to close the advanced therapy talent gap Cell and gene therapies: Opportunities for innovation Informing strategic decision-making in early clinical development This guide is free of charge […]

Join DDW, supported by Horizon Discovery for this exclusive free event which will examine CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event will take place on 9 June 2022, 3PM BST. Register for free here. Joanna Gawden-Bone, Manager, Cell Based Screening, Horizon […]

This 28-page DDW eBook, sponsored by Bio IVT, contains exclusive insight from industry experts on: Cell & gene therapies: the challenges and trends Battling the bottleneck: leveraging education to close the advanced therapy talent gap Cell and gene therapies: Opportunities for innovation Informing strategic decision-making in early clinical development This guide is free of charge […]

Antibodies are critical reagents applied in multiple biological areas, such as scientific research, therapeutics, and diagnosis. High-quality and reliable antibody reagents are the foundation of good assay performance. To learn more generating and validating critical antibody reagents join this free event hosted by DDW and supported by Sino Biological. It will take place on 16 […]

Drug discovery and development is a challenging multiparameter optimisation problem. Harnessing the power of artificial intelligence (AI) can help accurately predict the behaviour and properties of small molecules. In this on-demand webinar from X-Chem you will see: How AI and DNA-encoded library (DEL) screening are transforming early phase drug discovery How this can impact all stages […]

Drug discovery and development is a challenging multiparameter optimisation problem. Harnessing the power of artificial intelligence (AI) can help accurately predict the behaviour and properties of small molecules. In this on-demand webinar from X-Chem you will see: How AI and DNA-encoded library (DEL) screening are transforming early phase drug discovery How this can impact all stages […]